Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.

Factors contributing to malignant transformation of laryngeal pre-neoplastic lesions remain largely unknown. Potential etiologic factors may be related to a genetically controlled sensitivity to environmental carcinogens. In this study, we investigated bleomycin-induced chromosome fragility in 15 patients with laryngeal keratoses who experienced a malignant transformation of pre-neoplastic lesions during follow-up, as compared with chromosome fragility in 15 historical controls with no progression of laryngeal keratoses during a 10-year follow-up, in a match-paired analysis. Chromosomal analysis demonstrated a higher sensitivity to clastogens in patients with malignant progression of laryngeal pre-neoplastic lesions than that of control patients with no evolution of their original laryngeal keratoses (p < 0.01). Furthermore, in the attempt to identify possible prognostic markers we studied proliferative activity (MIB-1 expression) and p53 gene aberration in biopsy samples from non-invasive and invasive laryngeal lesions in both groups. p53 immunostaining was observed in 10/15 (66.7%) of pre-neoplastic lesions and in 11/15 (73.3%) of metachronous laryngeal cancers. No differences in terms of p53 expression were noted between transformed and not-transformed lesions. Mutations at p53 gene were observed in 3/15 (20%) of pre-invasive biopsies and in 4/5 (80%) of the laryngeal cancers analyzed. Our data suggest that p53 alteration is an early event in the genesis of a subset of laryngeal carcinomas and that there is no conclusive data about the possible clonal development of metachronous laryngeal carcinoma from a p53 mutated pre-invasive disease in the same patient. MIB-1 expression was found to progressively increase with degree of epithelial hyperplasia and dysplasia in both transformed (p = 0.007) and not-transformed (p < 0.1) lesions. Surprisingly, pre-invasive lesions with tumor evolution showed a lower proliferative activity when compared with laryngeal lesions without malignant transformation (p = 0.013). These data suggests that subjects with pre-neoplastic laryngeal lesion showing an increased susceptibility to carcinogens and with less proliferative disease could be at a higher risk for development of laryngeal carcinoma.
AuthorsO Gallo, A Franchi, I Chiarelli, B Porfirio, A Grande, L Simonetti, C Bocciolini, O Fini-Storchi
JournalActa oto-laryngologica. Supplementum (Acta Otolaryngol Suppl) Vol. 527 Pg. 30-8 ( 1997) ISSN: 0365-5237 [Print] NORWAY
PMID9197477 (Publication Type: Journal Article)
Chemical References
  • Antigens, Nuclear
  • Biomarkers
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Nuclear Proteins
  • Bleomycin
  • Antigens, Nuclear
  • Biomarkers (analysis)
  • Biomarkers, Tumor (analysis)
  • Biopsy
  • Bleomycin (pharmacology)
  • Carcinoma, Squamous Cell (genetics, pathology)
  • Case-Control Studies
  • Cell Transformation, Neoplastic
  • Chromosome Fragility
  • Epithelium (pathology)
  • Female
  • Genes, p53
  • Humans
  • Hyperplasia
  • Immunohistochemistry
  • Ki-67 Antigen
  • Laryngeal Diseases (genetics, pathology)
  • Laryngeal Mucosa (pathology)
  • Laryngeal Neoplasms (genetics, pathology)
  • Male
  • Middle Aged
  • Mutation
  • Nuclear Proteins (analysis)
  • Precancerous Conditions (genetics, pathology)
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: